NDA has been recognised as the Best Visionary, Health Government Regulatory Agency of the Year 2019. This was during the 7th Visionaries of Uganda Awards ceremony presided over by H.E Vice President of Uganda held at Kampala Serena Hotel, under the theme celebrating dynamic leadership and strengthening the fundamentals of the economy to achieve the Uganda vision 2040.

NDA HAS BEEN RECOGNIZED AS THE BEST VISIONARY, HEALTH GOVERNMENT REGULATORY AGENCY OF THE YEAR 2019

NDA INTRODUCES MOBILE MONEY PAYMENT SCHEME FOR NDAMIS GENERATED INVOICES
After successful roll out of NDAMIS system for managing most business processes, we are happy to introduce MM payment scheme

NDA ENFORCEMENT OPERATION
NDA Enforcement ongoing operation on unlicensed veterinary drug shops in trading centres (Kyeibuza, Kakyuku, and Bunonko) Kiruhura District

NDA CELEBRATES OPENING OF NEW SOUTH EASTERN REGIONAL OFFICE IN JINJA
Today NDA celebrates opening a new, strategically important South Eastern Regional Office in Jinja. This re-echos NDA’s presence in in all parts of Uganda as it strives to serve stakeholders better and, taking services closer to the grass root population.

SECRETARY TO THE AUTHORITY, MR DAVID NAHAMYA INTERACTING WITH NTV REGARDING NDA'S ROLE ON CURBING MIIRA ABUSE BY THE PUBLIC

ISO/IEC 17025:2005 ACCREDITATION
National Drug Quality Control Laboratory is ISO/IEC 17025:2005 Accredited

ISO 9001:2015 CERTIFICATION
National Drug Authority is ISO 9001:2015 Certified

NATIONAL DRUG AUTHORITY QUALITY POLICY
National Drug Authority (NDA) is committed to providing the highest standard of drug regulatory service to all customers.
* Click on the link to download
- CIRCULAR NO. 032- Presence of a potentially genotoxic impurity, N-nitrosodimethylamine (NDMA) in Ranitidine
- Adulterated Herbal products on the market
- Clarification on Hydrochlorothiazide
- Furosemide injection manufactured by Grand pharmaceutical (china) co., ltd; batch number 180120
- Disabling and potentially permanent side effects associated with quinolone and fluoroquinolone antibiotics
- Increased risk of non-melanoma skin cancer associated with HCTZ
- Implementation of Good Distribution Practices (GDP)
- Circular no.23 -suspension of registration of products from the Drug register
* Click on the link to download
- NDA PV bulletin June 2019
- NDA-PV bulletin - April 2019
- Frequently Asked Questions about National Drug Authority
- NDA-PV bulletin-Jan 2018
- Signed Joint Communique
- Stepwise guide for Product retention on NDAMIS.
- Addendum to 2018 Guidelines for the renewal of licenses for pharmacies
- Circular no. 15 - Gentamycin Injection
- Use of dietary supplements
- Circular NO 12 - market authorization holders
- Hepatitis B vaccination for adults
* Click on the link to download